Prosecutors filed a complaint Oct. 30 alleging pharmacist-in-charge Billy W. King II would fill suspicious prescriptions for highly addictive drugs that other Seashore Drugs pharmacists refused to fill, according to WECT. It also alleges that he and pharmacy owner John Waggett would willfully ignore red flags that violated the Controlled Substances Act, such as patients who requested suspicious drug combinations, visited multiple physicians for various prescriptions, paid with cash and sought an excessively high volume of pills.
The prosecutors also claim that Mr. King took no action after learning that customers were seen exchanging drugs outside Seashore Drugs after receiving their prescriptions, according to WECT.
Mr. Waggett and Mr. King agreed to pay a $1.05 million civil penalty, according to WECT. The filing would ban Mr. Waggett and Mr. King from “administering, dispensing, distributing, or possessing with intent to distribute, any kind of controlled substance,” but the agreement is awaiting approval from Ms. Flanagan, WECT reported.
More articles on opioids:
Documents show Sackler family’s involvement in opioid operations
Walmart pre-emptively sues US as part of opioid litigation battle
West Virginia court orders Walmart to turn over opioid documentation
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.